Berlex is committed to addressing unmet medical needs through research and development in the areas of oncology, gastroenterology, women's health, diagnostics and neurology. Berlex also markets diagnostic imaging agents, innovative treatments in the areas of female health care and oncology, as well as specialized therapeutics for life-threatening and disabling diseases of the central nervous system and cardiovascular system. Berlex has business operations in New Jersey, California and Washington.
| Website | http://www.berlex.com |
| Revenue | $116.4 million |
| Employees | View employees |
| Address | PO Box 1000, Montville, New Jersey 07045, US |
| Phone | +1 973-487-2000 |
| Industry | Healthcare, Pharmaceuticals, Drug Manufacturing & Research |
| Competitors | Merck & Co., Inc., Pfizer, Bayer, Novartis, Roche, AbbVie, Sanofi, GSK, Johnson & Johnson, AstraZeneca +42 more (view full list) |
| SIC | SIC Code 2834 Companies, SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Berlex , Inc. employee's phone or email?
Berlex , Inc. Questions
The Berlex , Inc. annual revenue was $116.4 million in 2026.
Berlex , Inc. is based in Montville, New Jersey.
The NAICS codes for Berlex , Inc. are [3254, 32541, 32, 325].
The SIC codes for Berlex , Inc. are [2834, 28, 283].
